Literature DB >> 34859929

Pain in irritable bowel syndrome: Does anything really help?

Joelle BouSaba1, Wassel Sannaa1, Michael Camilleri1.   

Abstract

Pain relief remains a significant challenge in the management of irritable bowel syndrome (IBS): "Does anything really help relieve the pain in patients with IBS?". Interventions aimed at pain relief in patients with IBS include diet, probiotics or antibiotics, antidepressants, antispasmodics, and drugs targeting specific gastrointestinal receptors such as opioid or histamine receptors. In the systematic review and meta-analysis published in this journal, Lambarth et al. examined the literature on the role of oral and parenteral anti-neuropathic agents in the management of pain in patients with IBS. This review article appraises their assessment of the efficacy of the anti-neuropathic agents amitriptyline, pregabalin, gabapentin, and duloxetine in the relief of abdominal pain or discomfort, and impact on overall IBS severity and quality of life. This commentary provides an update of current evidence on the efficacy of the dietary and pharmacological treatments that are available or in development, as well psychological and cognitive behavioral therapy for pain in IBS. Advances in recent years augur well for efficacious treatments that may expand the therapeutic arsenal for pain in IBS.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  antispasmodics; hypnotherapy; neuromodulators; peppermint oil; psychotherapy

Mesh:

Substances:

Year:  2021        PMID: 34859929      PMCID: PMC9017689          DOI: 10.1111/nmo.14305

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.960


  54 in total

Review 1.  Constipation: Advances in Diagnosis and Treatment.

Authors:  Arnold Wald
Journal:  JAMA       Date:  2016-01-12       Impact factor: 56.272

Review 2.  Targeting tachykinin receptors for the treatment of functional gastrointestinal disorders with a focus on irritable bowel syndrome.

Authors:  M Corsetti; F Akyuz; J Tack
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

3.  Oral and parenteral anti-neuropathic agents for the management of pain and discomfort in irritable bowel syndrome: A systematic review and meta-analysis.

Authors:  Andrew Lambarth; Natalia Zarate-Lopez; Alan Fayaz
Journal:  Neurogastroenterol Motil       Date:  2021-11-10       Impact factor: 3.598

4.  The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases.

Authors:  U R Juergens; M Stöber; H Vetter
Journal:  Eur J Med Res       Date:  1998-12-16       Impact factor: 2.175

5.  A controlled trial of psychological treatment for the irritable bowel syndrome.

Authors:  E Guthrie; F Creed; D Dawson; B Tomenson
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

Review 6.  Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  Reena Khanna; John K MacDonald; Barrett G Levesque
Journal:  J Clin Gastroenterol       Date:  2014-07       Impact factor: 3.062

7.  The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations.

Authors:  M Hawthorn; J Ferrante; E Luchowski; A Rutledge; X Y Wei; D J Triggle
Journal:  Aliment Pharmacol Ther       Date:  1988-04       Impact factor: 8.171

8.  Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.

Authors:  L A Houghton; C Fell; P J Whorwell; I Jones; D P Sudworth; J D Gale
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

9.  A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.

Authors:  Brooks D Cash; Michael S Epstein; Syed M Shah
Journal:  Dig Dis Sci       Date:  2015-08-29       Impact factor: 3.199

10.  Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.

Authors:  William D Chey; Gregory S Sayuk; Wilmin Bartolini; David S Reasner; Susan M Fox; Wieslaw Bochenek; Ramesh Boinpally; Elizabeth Shea; Kenneth Tripp; Niels Borgstein
Journal:  Am J Gastroenterol       Date:  2021-02-01       Impact factor: 12.045

View more
  1 in total

Review 1.  Heart Rate Variability-An Index of the Efficacy of Complementary Therapies in Irritable Bowel Syndrome: A Systematic Review.

Authors:  Magdalena Mróz; Marcin Czub; Anna Brytek-Matera
Journal:  Nutrients       Date:  2022-08-22       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.